Top Health Care Reform Stories
Supreme Court backs generic drug maker in 'skinny label' patent case
By Allison BellThe ERISA Industry called the ruling a victory for employers that want access to more generic drugs.
The latest news on health care reform and other regulation and compliance issues that are vital to benefits professionals. Insights and commentary about the latest proposals, and innovative strategies and ideas to ensure you stay focused on helping your customers while the debates rage on in Washington.
The ERISA Industry called the ruling a victory for employers that want access to more generic drugs.